{rfName}
De

License and use

Icono OpenAccess

Altmetrics

Grant support

This study has been co-funded by the European Regional Development Fund (EDRD). CG-V [FIS PI21/01640] have received research grants from the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III. The Project PI21/01640 has been funded by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was co-funded by a research grant (SGR 01324 Q5856414G) from the AGAUR (Agencia de Gestion de Ayudas Universitarias y de Investigacion) of Catalunya. A-TF has received a pre-doctoral grant supported by the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III [RH RH042953].

Impact on the Sustainable Development Goals (SDGs)

Analysis of institutional authors

Aiello, Tommaso FrancescoAuthorGarcia-Vidal, CarolinaCorresponding Author

Share

January 16, 2025
Publications
>
Letters

Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry

Publicated to:Haematologica. 109 (8): 2693-2700 - 2024-08-01 109(8), DOI: 10.3324/haematol.2023.284678

Authors: Aiello, Tommaso Francesco; Salmanton-Garcia, Jon; Marchesi, Francesco; Weinbergerova, Barbora; Glenthoj, Andreas; Van Praet, Jens; Farina, Francesca; Davila-Valls, Julio; Martin-Perez, Sonia; El-Ashwah, Shaimaa; Schonlein, Martin; Falces-Romero, Iker; Labrador, Jorge; Sili, Uluhan; Buquicchio, Caterina; Vena, Antonio; Plantefeve, Gaetan; Petzer, Verena; Biernat, Monika M; Lahmer, Tobias; Espigado, Ildefonso; Van Doesum, Jaap; Blennow, Ola; Piukovics, Klara; Tascini, Carlo; Samarkos, Michail; Bilgin, Yavuz M; Fianchi, Luana; Itri, Federico; Valkovic, Toni; Fracchiolla, Nicola S; Dargenio, Michelina; Jimenez, Moraima; Magyari, Ferenc; Lopez-Garcia, Alberto; Prezioso, Lucia; Colovic, Natasha; Shumilov, Evgenii; Abu-Zeinah, Ghaith; Krekeler, Carolin; Lavilla-Rubira, Esperanza; Papa, Mario Virgilio; Gonzalez-Lopez, Tomas Jose; Pinczes, Laszlo Imre; Demirkan, Fatih; Ali, Natasha; Besson, Caroline; Fouquet, Guillemette; Romano, Alessandra; Hernandez-Rivas, Jose-Angel; Del Principe, Maria Ilaria; Aujayeb, Avinash; Merelli, Maria; Lamure, Sylvain; De Almeida, Joyce Marques; Da Silva, Maria Gomes; Eisa, Noha; Meletiadis, Joseph; Rinaldi, Ikhwan; Finizio, Olimpia; Jaksic, Ozren; Delia, Mario; Nizamuddin, Summiya; Marchetti, Monia; Ijaz, Marriyam; Machado, Marina; Bailen-Almorox, Rebeca; Cernan, Martin; Coppola, Nicola; Gavriilaki, Eleni; Cattaneo, Chiara; Groh, Ana; Stojanoski, Zlate; Erben, Nurettin; Pantic, Nikola; Mendez, Gustavo-Adolfo; Di Blasi, Roberta; Meers, Stef; De Ramon, Cristina; Bahr, Nathan C; Emarah, Ziad; Varricchio, Gina; Cvetanoski, Milche; Garcia-Sanz, Ramon; Mitrovic, Mirjana; Lievin, Raphael; Hanakova, Michaela; Racil, Zdenek; Vehreschild, Maria; Tragiannidis, Athanasios; Rodrigues, Raquel Nunes; Garcia-Bordallo, Daniel; Cordoba, Raul; Cabirta, Alba; Nordlander, Anna; Ammatuna, Emanuele; Arellano, Elena; Wolf, Dominik; Prin, Romane; Limongelli, Alessandro; Bavastro, Martina; Colak, Gokce Melis; Grafe, Stefanie; Hersby, Ditte Stampe; Rahimli, Laman; Cornely, Oliver A; Garcia-Vidal, Carolina; Pagano, Livio

Affiliations

ADRZ, Dept Internal Med, Goes, Netherlands - Author
Aga Khan Univ, Karachi, Pakistan - Author
AORN Cardarelli, UOC Hematol, Naples, Italy - Author
AOUC Policlin, Hematol & Stem Cell Transplantat Unit, Bari, Italy - Author
Aristotle Univ Thessaloniki, Thessaloniki, Greece - Author
Aseer Cent Hosp, Abha, Saudi Arabia - Author
ASST Osped Civili, Hematol Unit, Brescia, Italy - Author
AZ Klina, Brasschaat, Belgium - Author
AZ Sint Jan Brugge Oostende AV, Dept Nephrol & Infect Dis, Brugge, Belgium - Author
Azienda Osped Nazl SS Antonio & Biagio & Cesare A, Alessandria, Italy - Author
Azienda Osped St Anna & San Sebastiano, Caserta, Italy - Author
Azienda Sanit Univ Friuli Cent, Udine, Italy - Author
Azienda Sanitaria Univ Friuli Cent, Udine, Italy - Author
CH Sud Francilien, Dept Hematol, Corbeil Essonnes, France - Author
Copenhagen Univ Hosp, Rigshosp, Dept Hematol, Copenhagen, Denmark - Author
Ctr Hosp Argenteuil, Argenteuil, France - Author
Ctr Hosp Versailles, Le Chesnay, France - Author
Dimiccoli Hosp, Hematol Dept, Barletta, Italy - Author
Dokuz Eylul Univ, Div Hematol, Izmir, Turkiye - Author
Eskisehir Osmangazi Univ, Dept Infect Dis & Clin Microbiol, Fac Med, Eskisehir, Turkiye - Author
Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy - Author
Fdn Jimenez Diaz Univ Hosp, Hlth Res Inst IIS FJD, Madrid, Spain - Author
Fdn Policlin Univ Agostino Gemelli IRCCS, Hematol Unit, Rome, Italy - Author
Gen Hosp Thessaloniki George Papanikolaou, Thessaloniki, Greece - Author
Hosp Escuela Agudos Dr Ramon Madariaga, Posadas, Argentina - Author
Hosp Gen Univ Gregorio Maranon, Clin Microbiol & Infect Dis Dept, Madrid, Spain - Author
Hosp Gen Univ Gregorio Maranon, Dept Hematol, Madrid, Spain - Author
Hosp Lucus Augusti, Lugo, Spain - Author
Hosp Nuestra Senora Sonsoles, Avila, Spain - Author
Hosp St Louis, Paris, France - Author
Hosp Univ Burgos, Dept Hematol, Burgos, Spain - Author
Hosp Univ Burgos, Res Unit, Dept Hematol, Burgos, Spain - Author
Hosp Univ Infanta Leonor, Madrid, Spain - Author
Hosp Univ Parma, Hematol & Bone Marrow Unit, Parma, Italy - Author
Hosp Univ Salamanca, Hematol Dept, Salamanca, Spain - Author
Inst Hematol & Blood Transfus, Prague, Czech Republic - Author
Inst Salud Carlos III, CIBERINFEC, Madrid, Spain - Author
IRCCS Osped San Raffaele, Milan, Italy - Author
IRCCS Regina Elena Natl Canc Inst, Hematol & Stem Cell Transplant Unit, Rome, Italy - Author
Ist Oncol Svizzera Italiana, Bellinzona, Switzerland - Author
Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden - Author
La Paz Univ Hosp, Madrid, Spain - Author
Laikon Gen Hosp, Athens, Greece - Author
Mansoura Univ, Oncol Ctr, Mansoura, Egypt - Author
Marmara Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Istanbul, Turkiye - Author
Masaryk Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic - Author
Med Univ Innsbruck, Dept Hematol & Oncol, Innsbruck, Austria - Author
Mem Canc Hosp & Res Ctr, Lahore, Pakistan - Author
Natl & Kapodistrian Univ Athens, Attikon Univ Gen Hosp, Sch Med, Clin Microbiol Lab, Athens, Greece - Author
Northumbria Healthcare, Newcastle, England - Author
Osped Ferrarotto, Div Clinicizzata Ematol, Catania, Italy - Author
Osped San Martino Genova, Genoa, Italy - Author
Palacky Univ, Fac Med & Dent, Dept Hematooncol, Olomouc, Czech Republic - Author
Portuguese Inst Oncol, Lisbon, Portugal - Author
San Luigi Gonzaga Hosp Orbassano, Orbassano, Italy - Author
Tech Univ Munich, Klinikum Rechts Isar, Med Klin 2, Munich, Germany - Author
UK Munster, Munster, Germany - Author
Univ Autonoma Barcelona, Dept Med, Bellaterra, Spain - Author
Univ Barcelona, Hosp Clin Barcelona IDIBAPS, Infect Dis Dept, Barcelona, Spain - Author
Univ Belgrade, Univ Clin Ctr Serbia, Med Fac, Belgrade, Serbia - Author
Univ Campania, Dept Mental Hlth & Publ Med, Naples, Italy - Author
Univ Clin Hematol, Skopje, North Macedonia - Author
Univ Cologne, Fac Med, Cologne, Germany - Author
Univ Debrecen, Dept Internal Med, Div Hematol, Fac Med, Debrecen, Hungary - Author
Univ Debrecen, Inst Internal Med, Div Hematol, Fac Med, Debrecen, Hungary - Author
Univ Hosp Cologne, Translat Res Cologne Excellence Cluster Cellular, Cologne, Germany - Author
Univ Hosp Ctr Rijeka, Rijeka, Croatia - Author
Univ Hosp Dubrava, Dept Hematol, Zagreb, Croatia - Author
Univ Hosp Munster UKM, Dept Med Hematol Oncol & Pneumol A, Munster, Germany - Author
Univ Hosp Olomouc, Olomouc, Czech Republic - Author
Univ Indonesia, Dept Internal Med, Div Hematol & Med Oncol, Fac Med,Cipto Mangunkusumo Hosp, Jakarta, Indonesia - Author
Univ Kansas, Med Ctr, Kansas City, MO USA - Author
Univ Klinikum Frankfurt Main, Infektiol, Frankfurt, Germany - Author
Univ Med Ctr Groningen, Groningen, Netherlands - Author
Univ Med Ctr Hamburg Eppendorf, Sect Pneumol, Dept Oncol Hematol & Bone Marrow Transplantat, Hamburg, Germany - Author
Univ Montpellier, Montpellier Univ Hosp, IGMM UMR5535 CNRS, Dept Clin Hematol, Montpellier, France - Author
Univ Paris Diderot, Serv Hematol Oncol, Hop St Louis, Assistance Publ Hop Paris, Paris, France - Author
Univ Paris Saclay, UVSQ, INSERM, Equipe Exposome & Heredite,CESP, Villejuif, France - Author
Univ Rijeka, Croatian Cooperat Grp Hematol Dis CROHEM, Fac Med, Rijeka, Croatia - Author
Univ Rijeka, Fac Hlth Studies, Rijeka, Croatia - Author
Univ Roma Tor Vergata, Dept Biomed & Prevent, Hematol, Rome, Italy - Author
Univ Seville, Univ Hosp Virgen Macarena, Inst Biomed Sevilla IBIS, Dept Hematol,Univ Hosp Virgen Rocio,CSIC, Seville, Spain - Author
Univ Szeged, Dept Internal Med, South Div, Fac Med, Szeged, Hungary - Author
USAL, IBSAL, Ctr Invest Canc IBMCC, CSIC, Salamanca, Spain - Author
Vall dHebron Hosp Univ, Vall dHebron Barcelona Hosp Campus, Vall dHebron Inst Oncol VHIO, Dept Hematol,Expt Hematol, Barcelona, Spain - Author
Vito Fazzi, Hematol & Stem Cell Transplant Unit, Lecce, Italy - Author
Weill Cornell Med, Div Hematol & Oncol, New York, NY USA - Author
Wroclaw Med Univ, Dept Hematol Blood Neoplasms & Bone Marrow Transp, Wroclaw, Poland - Author
See more

Abstract

Not available.

Keywords

AdultAgedAged, 80 and overAntiviral therapyAntivirus agentComorbidityComplicationControlled studyCoronavirus disease 2019Covid-19Covid-19 drug treatmentCovid-19 pharmacotherapyDexamethasoneDiagnostic test accuracy studyDisease severityDrug therapyFemaleGood health and well-beingHematologic diseaseHematologic malignancyHematologic neoplasmsHumanHumansIsolation and purificationLetterLymphocytopeniaMajor clinical studyMaleMiddle agedMonoclonal antibodyMonotherapyMortalityMortality ratePropensity scoreReceiver operating characteristicRegisterRegistriesSars-cov-2Sensitivity analysisSevere acute respiratory syndrome coronavirus 2SmokingVaccinationVery elderly

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Haematologica due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2024 there are still no calculated indicators, but in 2023, it was in position 11/98, thus managing to position itself as a Q1 (Primer Cuartil), in the category Hematology.

Independientemente del impacto esperado determinado por el canal de difusión, es importante destacar el impacto real observado de la propia aportación.

Según las diferentes agencias de indexación, el número de citas acumuladas por esta publicación hasta la fecha 2025-08-02:

  • Open Alex: 1
  • WoS: 2
  • Scopus: 1

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-08-02:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 7.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 9 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 17.55.
  • The number of mentions on the social network X (formerly Twitter): 28 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.
Continuing with the social impact of the work, it is important to emphasize that, due to its content, it can be assigned to the area of interest of ODS 3 - Good Health And Well-being, with a probability of 84% according to the mBERT algorithm developed by Aurora University.

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Argentina; Austria; Belgium; Croatia; Czech Republic; Denmark; Egypt; France; Germany; Greece; Hungary; Indonesia; Italy; Macedonia; Netherlands; Pakistan; Poland; Portugal; Saudi Arabia; Serbia; Sweden; Switzerland; Turkey; United Kingdom; United States of America.

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (Aiello, Tommaso Francesco) .

the author responsible for correspondence tasks has been Garcia Vidal, Carolina.